Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9618 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9618 |
High Similarity |
NPD6166 |
Phase 2 |
0.9618 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9351 |
High Similarity |
NPD1934 |
Approved |
0.9167 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9141 |
High Similarity |
NPD7074 |
Phase 3 |
0.908 |
High Similarity |
NPD7054 |
Approved |
0.9051 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.9024 |
High Similarity |
NPD7472 |
Approved |
0.897 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8924 |
High Similarity |
NPD2801 |
Approved |
0.8855 |
High Similarity |
NPD6797 |
Phase 2 |
0.8831 |
High Similarity |
NPD1511 |
Approved |
0.8827 |
High Similarity |
NPD6959 |
Discontinued |
0.8802 |
High Similarity |
NPD7251 |
Discontinued |
0.8788 |
High Similarity |
NPD3818 |
Discontinued |
0.875 |
High Similarity |
NPD7808 |
Phase 3 |
0.8734 |
High Similarity |
NPD4380 |
Phase 2 |
0.8718 |
High Similarity |
NPD1512 |
Approved |
0.8696 |
High Similarity |
NPD3882 |
Suspended |
0.8642 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD3817 |
Phase 2 |
0.8562 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD5494 |
Approved |
0.8519 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD1549 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8402 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8323 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8302 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8294 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8284 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8141 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8072 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8061 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8046 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8034 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7976 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7935 |
Intermediate Similarity |
NPD943 |
Approved |
0.7935 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7908 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7849 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7714 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD919 |
Approved |
0.7605 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7593 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7561 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7547 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.753 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7438 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7427 |
Intermediate Similarity |
NPD37 |
Approved |
0.7425 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7425 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7425 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7407 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7399 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7399 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7348 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7338 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7278 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7259 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7254 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7253 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7251 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD920 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7074 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7043 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7 |
Intermediate Similarity |
NPD5711 |
Approved |
0.699 |
Remote Similarity |
NPD7680 |
Approved |
0.6982 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6973 |
Remote Similarity |
NPD7039 |
Approved |
0.6973 |
Remote Similarity |
NPD7038 |
Approved |
0.6971 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD8319 |
Approved |
0.694 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6933
|
Remote Similarity |
NPD3268 |
Approved |